References
Flood MP, Kong JC, Wilson K, Mohan H, Waters PS, McCormick JJ, et al. The impact of neoadjuvant chemotherapy on the surgical management of colorectal peritoneal metastases: a systematic review and meta-analysis. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-11699-7.
Repullo D, Barbois S, Leonard D, Bohlok A, Van den Audenaeren E et al. The absence of benefit of perioperative chemotherapy in initially resectable peritoneal metastases of colorectal cancer origin treated with complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a retrospective analysis. Eur J Surg Oncol. https://doi.org/10.1016/j.ejso.2021.01.018
Rovers KP, Bakkers C, Simkens GA, et al. Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II–III, randomised, superiority study (CAIRO6). BMC Cancer. 2019;19(1):390. https://doi.org/10.1186/s12957-018-1554-8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The authors declare no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Liberale, G., Moreau, M. & Repullo, D. Comments on “The Impact of Neoadjuvant Chemotherapy on the Surgical Management of Colorectal Peritoneal Metastases: A Systematic Review and Meta-analysis”. Ann Surg Oncol 29, 7933–7934 (2022). https://doi.org/10.1245/s10434-022-12514-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-022-12514-z